Can an App Supporting Psoriasis Patients Improve Adherence to Topical Treatment? A Single-blind Randomized Controlled Trial

Overview

Journal BMC Dermatol

Publisher Biomed Central

Specialty Dermatology

Date 2018 Feb 9

PMID 29415699

Citations 5

Authors

Mathias Tiedemann Svendsen

Flemming Andersen

Kirsten Hammond Andersen

Klaus Ejner Andersen

Affiliations

Soon will be listed here.

Abstract

Background: Topical corticosteroid or corticosteroid/calcipotriol preparations are recommended first-line topical treatments of psoriasis, but a main cause for the lack of efficacy of topical treatments is considered low rates of adherence to topical drugs. Patient support by the use of applications (apps) for smartphones is suggested to improve medical adherence.

Methods/design: Design: An investigator-initiated, single-center, single-blind, parallel-group, phase-4 clinical superiority randomized controlled trial (RCT).

Participants: 134 patients 18 to 75 years of age with mild-to-moderate psoriasis, who are capable of reading English language, own a smartphone, and are candidates for the study drug calcipotriol and betamethasone dipropionate (Cal/BD) cutaneous foam once daily prn (pro re nata).

Intervention: A 28-day adherence-supporting app providing compulsory daily treatment reminders that pop-up on the smartphone screen with a short alert sound. The app synchronizes through Bluetooth® to an electronic monitor (EM) attached to the medication canister. The EM contains a chip registering the amount of foam, day and time the patient use the foam dispenser. The information is displayed in a diary that shows the amount of Cal/BD cutaneous foam used and the number of applied treatment sessions. The app has an optional diary with the patient's rating of symptoms. Non-intervention: Use of Cal/BD cutaneous foam and EM without the app. All participants are prescribed Cal/BD cutaneous foam prn for the entire study period. Primary outcome obtained in week 4: rates of adherence measured by patient report, weight of medication canisters, and number of treatment sessions measured by the EM. Secondary outcomes obtained at baseline, weeks 4, 8, and 26: Lattice System Physician's Global Assessment (LS-PGA) and Dermatology Quality of Life Index (DLQI).

Discussion: This trial tests of whether an app can improve rates of adherence to a topical antipsoriatic drug. If the app improves rates of adherence and reduces the burden of psoriasis in a clinically significant way, the app could easily be implemented as a standard routine of care in the clinic.

Trial Registration: NCT02858713 , registered on August 3, 2016. EudraCT number 2016-002143-42.

Citing Articles

Current Insights on Treatment Adherence in Prevalent Dermatological Conditions and Strategies To Optimize Adherence Rates.

Cirstea N, Radu A, Vesa C, Radu A, Bungau A, Tit D Cureus. 2024; 16(9):e69764.

PMID: 39429316 PMC: 11490752. DOI: 10.7759/cureus.69764.

Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach.

Beauvais C, Pham T, Montagu G, Gleizes S, Madrisotti F, Lafourcade A PLoS One. 2022; 17(9):e0272235.

PMID: 36107954 PMC: 9477307. DOI: 10.1371/journal.pone.0272235.

Pros and cons of eHealth: A systematic review of the literature and observations in Denmark.

Svendsen M, Tiedemann S, Andersen K SAGE Open Med. 2021; 9:20503121211016179.

PMID: 34046178 PMC: 8135209. DOI: 10.1177/20503121211016179.

Use of Mobile Applications in Dermatology.

Kaliyadan F, Ashique K Indian J Dermatol. 2020; 65(5):371-376.

PMID: 33165393 PMC: 7640802. DOI: 10.4103/ijd.IJD_422_20.

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases.

Najm A, Nikiphorou E, Kostine M, Richez C, Pauling J, Finckh A RMD Open. 2019; 5(2):e001014.

PMID: 31565245 PMC: 6744072. DOI: 10.1136/rmdopen-2019-001014.

References

Balato N, Megna M, Di Costanzo L, Balato A, Ayala F . Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol. 2012; 168(1):201-5. DOI: 10.1111/j.1365-2133.2012.11205.x. View

Storm A, Benfeldt E, Andersen S, Serup J . A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008; 59(6):975-80. DOI: 10.1016/j.jaad.2008.07.039. View

Gold L, Corvari L . The roles of safety and compliance in determining effectiveness of topical therapy for psoriasis. Cutis. 2007; 79(1 Suppl 2):32-8. View

Zaghloul S, Goodfield M . Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004; 140(4):408-14. DOI: 10.1001/archderm.140.4.408. View

Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A . Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015; 42(4):367-72. DOI: 10.1111/1346-8138.12804. View

Yentzer B, Alikhan A, Teuschler H, Williams L, Tusa M, Fleischer Jr A . An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol. 2009; 60(5):879-80. DOI: 10.1016/j.jaad.2008.11.019. View

Feldman S . Disease burden and treatment adherence in psoriasis patients. Cutis. 2013; 92(5):258-63. View

Storm A, Andersen S, Benfeldt E, Serup J . One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008; 59(1):27-33. DOI: 10.1016/j.jaad.2008.03.045. View

Trevena L . There's an App for That: A Guide for Healthcare Practitioners and Researchers on Smartphone Technology. Online J Public Health Inform. 2015; 7(2):e218. PMC: 4576443. DOI: 10.5210/ojphi.v7i2.5522. View

10.

Svedbom A, Dalen J, Mamolo C, Cappelleri J, Petersson I, Stahle M . Treatment patterns with topicals, traditional systemics and biologics in psoriasis - a Swedish database analysis. J Eur Acad Dermatol Venereol. 2014; 29(2):215-223. DOI: 10.1111/jdv.12494. View

11.

Koo J, Tyring S, Werschler W, Bruce S, Olesen M, Villumsen J . Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study. J Dermatolog Treat. 2015; 27(2):120-7. PMC: 4772687. DOI: 10.3109/09546634.2015.1083935. View

12.

Svendsen M, Jeyabalan J, Andersen K, Andersen F, Johannessen H . Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review. J Dermatolog Treat. 2016; 28(5):374-383. DOI: 10.1080/09546634.2016.1254331. View

13.

Saeki H, Watanabe A, Tada Y, Kakinuma T, Komine M, Ihn H . Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid. J Dermatol. 2008; 35(9):601-3. DOI: 10.1111/j.1346-8138.2008.00531.x. View

14.

Mason A, Mason J, Cork M, Dooley G, Hancock H . Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 2013; (3):CD005028. PMC: 11227123. DOI: 10.1002/14651858.CD005028.pub3. View

15.

Svendsen M, Andersen F, Hansen J, Johannessen H, Andersen K . Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review. J Dermatolog Treat. 2016; 28(1):32-39. DOI: 10.1080/09546634.2016.1178375. View

16.

Krejci-Manwaring J, Tusa M, Carroll C, Camacho F, Kaur M, Carr D . Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007; 56(2):211-6. DOI: 10.1016/j.jaad.2006.05.073. View

17.

Berth-Jones J, Grotzinger K, Rainville C, Pham B, Huang J, Daly S . A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol. 2006; 155(4):707-13. DOI: 10.1111/j.1365-2133.2006.07389.x. View

18.

Chow C, Simpson M, Luger T, Chubb H, Ellis C . Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment. J Eur Acad Dermatol Venereol. 2015; 29(7):1406-14. DOI: 10.1111/jdv.13132. View

19.

Brown K, Rehmus W, Kimball A . Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006; 55(4):607-13. DOI: 10.1016/j.jaad.2005.12.021. View

20.

Svendsen M, Andersen F, Andersen K . eHealth Technologies as an intervention to improve adherence to topical antipsoriatics: a systematic review. J Dermatolog Treat. 2017; 29(2):123-128. DOI: 10.1080/09546634.2017.1341612. View